TFS Capital’s TRACON Pharmaceuticals TCON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-84
Closed -$82K – 884
2016
Q4
$82K Buy
+84
New +$96K 0.02% 659
2016
Q1
– Sell
-52
Closed -$96K – 1117
2015
Q4
$96K Sell
52
-33
-39% -$66K 0.01% 662
2015
Q3
$165K Buy
+85
New +$199K 0.02% 765

Other funds holding TCON

TFS Capital's TCON Position: Q1 2017 in Review

TFS Capital sold out of TRACON Pharmaceuticals (TCON) in Q1 2017, closing a stake of 84 shares — an estimated $82K sold.

TFS Capital first reported a position in TCON in Q3 2015 and held it in 3 quarters. The position peaked at $165K in Q3 2015. 22 funds tracked by Wall St. Rank hold TCON as of Q1 2017.

  • TFS Capital reported no remaining TRACON Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • TFS Capital sold 84 TRACON Pharmaceuticals shares in Q1 2017, an estimated $82K.
  • TFS Capital first reported a position in TRACON Pharmaceuticals in Q3 2015 and held it in 3 quarters.
  • TFS Capital's TRACON Pharmaceuticals position peaked at $165K in Q3 2015.
  • 22 funds tracked by Wall St. Rank held TRACON Pharmaceuticals as of Q1 2017.

Based on TFS Capital's 13F filing for Q1 2017, filed 5 May 2017.